Filing Details
DBV Technologies S.A. (NASDAQ:DBVT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 16, 2026.
The Healthcare company reported Q0 revenue of .
Filing Details DBV Technologies S.A. (NASDAQ:DBVT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 16, 2026. The Healthcare company…

DBV Technologies S.A. (NASDAQ:DBVT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 16, 2026.
The Healthcare company reported Q0 revenue of .
DBV Technologies S.A.'s stock currently trades at $14.86 with a market capitalization of $464.6M.
The 10-Q provides DBV Technologies S.A.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for DBV Technologies S.A. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DBVT Stock Page
Browse all filings on our DBVT SEC filings page.
Public companies like DBV Technologies S.A. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · DBVT
$13.54
Up: +$0.28 · +2.07%
Live quote updated
Keep reading